MedPath

The study of the effect of Thyme oxymel on over weight

Phase 3
Conditions
obesity - over weight.
Obesity, unspecified
Registration Number
IRCT20171220037976N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
108
Inclusion Criteria

Body mass index (BMI) above 25 kg / m
Conscious Consent to Participate in the Study
Waist to hip ratio index (WHR) in men1 and women 0.9
Not taking any medications in the past month

Exclusion Criteria

pregnancy
lactation
alcohol use
diabetes melitus
thymus allergy reaction history
acute or chronic liver disease
cancer
hypo or hyper thyroidism
renal failuer
Gastroesophageal reflux
Unwillingness of the patient to continue participating in the plan for any reason

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body Mass Index. Timepoint: monthly. Method of measurement: From the division of weight into squared height.
Secondary Outcome Measures
NameTimeMethod
ipid profile study. Timepoint: At the start and end of study. Method of measurement: blood sampling.;Liver enzyme study. Timepoint: At the start and end of study. Method of measurement: blood sampling.;Abdominal to hip circumference ratio study. Timepoint: monthly. Method of measurement: by meter.;Weight. Timepoint: monthly. Method of measurement: scale.
© Copyright 2025. All Rights Reserved by MedPath